Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Keidanren, Nikkeiren Propose Senior Healthcare System
May 28, 2001
- JSMBE Advocates IT Revolution in BME
May 28, 2001
- Eisai Reorganizes R&D System to Accelerate Clinical Trials in Japan
May 28, 2001
- Benefits under Government-managed Health Insurance Down 1.7% to \4,207.6 Bil.
May 28, 2001
- Fresenius Completes New CAPD System Plant in Buzen
May 28, 2001
- Securities Analyst Recommends Win-win M&As to Domestic Drug Companies
May 28, 2001
- Yamanouchi to Tie Up with Hitachi for Genomic Drug Discovery
May 28, 2001
- BSJ: New Product in Maverick Series
May 28, 2001
- Takeda, Pharmacia Tie Up for Marketing of OTC NRT Products
May 28, 2001
- International A-II Symposium 2001 Held by Banyu
May 28, 2001
- DIAGNOSTIC NEWS IN BRIEF -1-
May 28, 2001
- Meiji Seika, Solvay to Codevelop Drug for Parkinson's Disease
May 28, 2001
- Sun Drug: Sales, Profits Show Double-Digit Increases
May 28, 2001
- DIAGNOSTIC NEWS IN BRIEF -2-
May 28, 2001
- Current Status of Antibody Drug Development Reported: PMSRL Seminar
May 28, 2001
- ABBREVIATION OF THE WEEK
May 28, 2001
- BUSINESS NEWS IN BRIEF -1-
May 28, 2001
- Terumo: Consolidated Sales Increase for 7 Consecutive Years to \176 Bil.
May 28, 2001
- BUSINESS NEWS IN BRIEF -2-
May 28, 2001
- NEDO to Develop Gene Diagnosis System for Cancer, Therapeutic Systems for Cardiac Disease
May 28, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…